Twenty-two targets were enriched in pathways in cancer (Figure 8), which contained AR signaling pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, estrogen signaling pathway, p53 signaling pathway, and cell cycle. This evidence concerns the gene PIK3CG and cancer.